Human Genome Sciences. (Active Pharmaceutical Ingredient Watch).(LymphoStat-B shows positive results in trial)(Brief Article)

Chemical Market Reporter, April, 2003

HUMAN GENOME SCIENCES reported positive results from a Phase I clinical trial of LymphoStat-B, a human monoclonal antibody to B-lymphocyte stimulator, BLyS, in systemic lupus erythematosus. The company plans to initiate Phase II clinical trials of LymphoStat-B to treat lupus and rheumatoid arthritis in 2003.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement